Hematopoietic Stem Cell Transplantation-related Conditions
📧 Sign up to get email alerts when something new happens for Hematopoietic Stem Cell Transplantation-related Conditions.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-08-06EMA Authorised: Thiotepa Riemser (thiotepa) — Esteve Pharmaceuticals GmbH
The EMA has authorised Thiotepa Riemser (thiotepa) for hematopoietic stem cell transplantation and neoplasms, with Esteve Pharmaceuticals Gm…
-
EMA approval · 2023-10-23EMA Authorised: Thiotepa Riemser (thiotepa) — Esteve Pharmaceuticals GmbH
EMA authorised Thiotepa Riemser for indications related to hematopoietic stem cell transplantation and neoplasms.